March Altus Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$1.07M Sell
13,310
-13,500
-50% -$1.08M 6.68% 6
2016
Q2
$2.11M Hold
26,810
16.32% 2
2016
Q1
$1.93M Buy
26,810
+17,912
+201% +$1.36M 19.98% 1
2015
Q4
$750K Sell
8,898
-7,946
-47% -$659K 6.9% 8
2015
Q3
$1.41M Buy
16,844
+1,106
+7% +$93.4K 8.3% 4
2015
Q2
$1.31M Buy
15,738
+1,546
+11% +$118K 7.64% 3
2015
Q1
$1.03M Sell
14,192
-141,225
-91% -$10.1M 6.48% 8
2014
Q4
$10.7M Sell
155,417
-46,031
-23% -$3.11M 4.9% 11
2014
Q3
$13.1M Sell
201,448
-109,469
-35% -$6.93M 5.2% 5
2014
Q2
$19.3M Buy
310,917
+42,830
+16% +$2.56M 7.08% 2
2014
Q1
$15.8M Buy
268,087
+41,249
+18% +$2.3M 5.07% 4
2013
Q4
$11.6M Buy
+226,838
New +$11.4M 3.5% 14

Other funds holding LLY

March Altus Capital Management's LLY Position: Q3 2016 in Review

March Altus Capital Management reduced its Eli Lilly (LLY) stake by 50% in Q3 2016, selling an estimated $1.08M and leaving 13,310 shares worth $1.07M. The position accounts for 6.68% of the portfolio, ranked #6.

March Altus Capital Management first reported a position in LLY in Q4 2013 and has held it in 12 quarters since. The position peaked at $19.3M in Q2 2014. 1,177 funds tracked by Wall St. Rank hold LLY as of Q3 2016.

  • March Altus Capital Management held 13,310 shares of Eli Lilly worth $1.07M as of Q3 2016.
  • March Altus Capital Management sold 13,500 Eli Lilly shares in Q3 2016, an estimated $1.08M.
  • Eli Lilly made up 6.68% of March Altus Capital Management's portfolio in Q3 2016, its #6 holding.
  • March Altus Capital Management first reported a position in Eli Lilly in Q4 2013 and has held it in 12 quarters since.
  • March Altus Capital Management's Eli Lilly position peaked at $19.3M in Q2 2014.
  • 1,177 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2016.

Based on March Altus Capital Management's 13F filing for Q3 2016, filed 7 Nov 2016.